Fleichman Marina, Schneider Tim, Fetscher Charlotte, Michel Martin C
Department of Medicine, University of Essen, Germany.
J Pharmacol Exp Ther. 2004 Jan;308(1):54-8. doi: 10.1124/jpet.103.058255. Epub 2003 Oct 7.
We have investigated the role of several protein kinases in carbachol-stimulated, M(3) muscarinic receptor-mediated contraction of rat urinary bladder. Concentration-response curves for the muscarinic receptor agonist carbachol were generated in the presence of multiple concentrations of inhibitors of various protein kinases, their inactive controls, or their vehicles. Bladder contraction was not significantly inhibited by three protein kinase C inhibitors (chelerythrine, 1-10 microM; calphostin C, 0.1-1 microM; and 2-[1-(3-dimethylaminopropyl)-1H-indol-3-yl]-3-(1H-indol-3-yl)-maleimide (Gö 6850), 1-10 microM), by the tyrosine kinase inhibitor genistein or its inactive control daidzein (3-30 microM each), or by two inhibitors of activation of mitogen-activated protein kinase [10-100 microM 2'-amino-3'-methoxyflavone (PD 98,059) and 3-30 microM 1,4-diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (U 124)] or their negative control 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U 126) (3-30 microM). Although high concentrations of wortmannin (3-30 microM) inhibited bladder contraction, this was not mimicked by another inhibitor of phosphatidylinositol-3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY 294,002) (3-30 microM) and, hence, was more likely due to direct inhibition of myosin light chain kinase by wortmannin than to an involvement of phosphatidylinositol-3-kinase. In contrast, trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide (Y 27,632) (1-10 microM), an inhibitor of rho-associated kinases, concentration-dependently and effectively attenuated the carbachol responses. We conclude that carbachol-induced contraction of rat urinary bladder does not involve protein kinase C, phosphatidylinositol-3-kinase, tyrosine kinases, or extracellular signal-regulated kinases; in contrast, rho-associated kinases appear to play an important role in the regulation of bladder contraction.
我们研究了几种蛋白激酶在卡巴胆碱刺激的、M(3)毒蕈碱受体介导的大鼠膀胱收缩中的作用。在多种浓度的各种蛋白激酶抑制剂、其无活性对照物或其溶剂存在的情况下,生成了毒蕈碱受体激动剂卡巴胆碱的浓度-反应曲线。三种蛋白激酶C抑制剂(白屈菜红碱,1 - 10微摩尔;钙磷蛋白C,0.1 - 1微摩尔;以及2 - [1 - (3 - 二甲氨基丙基)-1H - 吲哚 - 3 - 基]-3 - (1H - 吲哚 - 3 - 基)-马来酰亚胺(Gö 6850),1 - 10微摩尔)、酪氨酸激酶抑制剂染料木黄酮或其无活性对照黄豆苷元(各3 - 30微摩尔)、两种丝裂原活化蛋白激酶激活抑制剂[10 - 30微摩尔2'-氨基-3'-甲氧基黄酮(PD 98,059)和3 - 30微摩尔1,4 - 二氨基-2,3 - 二氰基-1,4 - 双(2 - 氨基苯硫基)丁二烯(U 124)]或其阴性对照1,4 - 二氨基-2,3 - 二氰基-1,4 - 双(甲硫基)丁二烯(U 126)(3 - 30微摩尔)均未显著抑制膀胱收缩。尽管高浓度的渥曼青霉素(3 - 30微摩尔)抑制膀胱收缩,但另一种磷脂酰肌醇-3 - 激酶抑制剂2 - (4 - 吗啉基)-8 - 苯基-4H - 1 - 苯并吡喃-4 - 酮(LY 294,002)(3 - 30微摩尔)并未模拟出这种抑制作用,因此,更可能是由于渥曼青霉素直接抑制肌球蛋白轻链激酶,而非磷脂酰肌醇-3 - 激酶的参与。相比之下,rho相关激酶抑制剂反式-4 - [(1R)-1 - 氨基乙基]-N - 4 - 吡啶基环己烷甲酰胺(Y 27,632)(1 - 10微摩尔)浓度依赖性地有效减弱了卡巴胆碱反应。我们得出结论,卡巴胆碱诱导的大鼠膀胱收缩不涉及蛋白激酶C、磷脂酰肌醇-3 - 激酶、酪氨酸激酶或细胞外信号调节激酶;相反,rho相关激酶似乎在膀胱收缩调节中起重要作用。